Türk Doğa ve Fen Dergisi, vol.9, no.2, pp.201-210, 2020 (Peer-Reviewed Journal)
Due to the increasing world population and food need, genetically modified organisms
and their products are obtained by using recombinant DNA technologies developed as a result of
the technological developments in the last quarter century. It is thought that they may have a
potential risk from new genetic material transferred to organisms. It is whether it harms the health
of living organism due to these risks, and These risks are whether there are any negative effects on
other species. Despite successful results can be achieved against various stress factors, it has not
been possible to prevent unintended consequences. In addition to this, productions of transgenic
have reached a large plantation area and trade volume globally. All these positive and negative
opinions cause legal practices covering the biosafety risks and measures for these products. The
reasons for the implementation of these laws are to incorporate such studies into a certain ethical
framework, prevent human health and ecological negativities by ensuring food safety and quality.
Legal frameworks of biosafety laws should be taken into consideration in order to create an
effective public perception regarding the discovery of the advantages, disadvantages or risks of
these products as well as scientific and technological developments. In this study, the evaluation,
management and communication of the biosafety risks including the research, development,
placing on the market, monitoring, import and export of genetically modified organisms and their
products are discussed.